Maximilian Stahl, MD^1,2, Kamal Menghrajani, MD¹, Andriy Derkach, PhD^3*, Alexander Chan, MD^4*, Wenbin Xiao, MD, PhD^4,5, Jacob L Glass, MD, PhD^1,6, Amber C. King, PharmD, BCOP⁷, Anthony Daniyan, MD⁸, Christopher Famulare, MS^9*, Bernadette M. Cuello, BSN, MSN, NP, RN^1*, Omar Abdel-Wahab, MD ^1,10, Ross L. Levine, MD^1,10, Aaron D Viny, MD, MS^1,10, Eytan M. Stein, MD^1,2, Mikhail Roshal, MD, PhD⁴, Martin S. Tallman, MD ^2,11 and Aaron D Goldberg, MD, PhD¹²

¹Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Weill Cornell Medical College, New York, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York
⁶Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, NY, NY
⁹Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Memorial Sloan-Kettering Cancer Center, New York, NY
¹²Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY

Thomas Prebet, MD, PhD¹, Robert J. Ryan^2* and Stefan Faderl³

¹Yale School of Medicine, New Haven, CT
²Jazz Pharmaceuticals, Philadelphia, PA
³Jazz Pharmaceuticals, Palo Alto, CA

Gee Youn (Geeny) Kim, PharmD^1*, Jamie L. Koprivnikar, MD², Rebecca Testi, MSN, RN, APN-C, OCN^3*, Tara McCabe, FNP-C, MSN, RN, BSN^2*, Grace Perry, MSN, RN, APN-C, OCN^2*, Danielle Marcotulli, MSN, RN, FNP-BC, AOCNP^3*, Elizabeth Jones, BSN, RN, OCN^4*, Xue Geng, MS^5*, Ming Tan^6* and James K. McCloskey, MD⁷

¹Department of Pharmacy and Clinical Services, Hackensack Meridian Health, Hackensack, NJ
²John Theurer Cancer Center, Division of Leukemia, Hackensack Meridian Health, Hackensack Medical Center, NJ
³John Theurer Cancer Center, Division of Leukemia, Hackensack Meridian Health, Hackensack, NJ
⁴John Theurer Cancer Center, Division of Leukemia, Hackensack Meridian, Hackensack Medical Center, NJ
⁵Department of Biostatistics, Bioinformatics, and Bioinformatics, Georgetown University Hospital/Lombardi Comprehensive Cancer Center, Washington, DC
⁶Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Hospital/Lombardi Comprehensive Cancer Center, Washington, DC
⁷John Thuerer Cancer Center, Division of Leukemia, Hackensack University Medical Center, Hackensack, NJ

Brian A Jonas, MD, PhD, FACP¹, Courtney D. Dinardo, MD, MSc², Nicola Fracchiolla^3*, Alexander Pristupa, MD^4*, Kenichi Ishizawa, MD, PhD^5*, Jie Jin, MD, PhD^6*, Marina Konopleva, MD, PhD², Yishai Ofran^7*, Pau Montesinos, MD, PhD^8*, Tibor Kovacsovics, MD⁹, Jun-Ho Jang, MD^10*, Hagop M. Kantarjian, MD¹¹, Wan-Jen Hong, MD¹², Yinghui Duan, PhD^13*, William Ainsworth¹⁴, Jalaja Potluri, MD¹³, Michael Werner^14*, Anders Erik Svensson, MD^14* and Keith W. Pratz, MD¹⁵

¹Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
⁴Ryazan Regional Clinical Hospital, Ryazan, RUS
⁵Yamagata University, Yamagata, YAM, Japan
⁶The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China
⁷Rambam Health Care Campus and Faculty of Medicine Technion, Haifa, Israel
⁸Hospital Universitari i Politecnic la Fe, Valencia, and CIBERONC Instituto de Salud Carlos III, Madrid, Spain
⁹University of Utah, Salt Lake City, UT
¹⁰Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹¹Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹²Genentech, Inc., South San Francisco, CA
¹³AbbVie Inc., North Chicago, IL
¹⁴AbbVie, Inc., North Chicago, IL
¹⁵Department of Medicine, Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia, PA

Doerthe Eckert, MSc^1*, Deanna Brackman, PhD^2*, Rajeev Menon, PhD^2*, Ahmed Hamed Salem, PhD, FCP², Jalaja Potluri, MD², B. Douglas Smith, MD^3*, Andrew H. Wei⁴, John Hayslip, MD, MSCR⁵, Dale Miles, PhD^6*, Sven Mensing, PhD^1*, Sathej Gopalakrishnan, PhD^1* and Jiuhong Zha, PhD^7*

¹Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH Co. KG, Ludwigshafen, Germany
²AbbVie Inc., North Chicago, IL
³Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁴Department of Haematology, Alfred Hospital and Monash University, Melbourne, Australia
⁵Oncology Development, AbbVie Inc., North Chicago, IL
⁶Genentech Inc., South San Francisco, CA
⁷Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL

Qi Wang^1*, Todd M. Cooper, DO², Michael J. Absalon³, E. Anders Kolb, MD⁴, Grygoriy Vasilinin^5*, Nathalie H. Gosselin^5*, Todd A. Alonzo, PhD^6* and J.F. Marier^5*

¹Jazz Pharmaceuticals, Palo Alto, CA
²Seattle Children’s Hospital, Cancer and Blood Disorders Center, Seattle, WA
³Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
⁴Center for Cancer and Blood Disorders, Nemours Alfred I. duPont Hospital for Children, Wilmington, DE
⁵Certara, Princeton, NJ
⁶University of Southern California, Los Angeles, CA

Hong-Hu Zhu, MD^1*, Min Ji, MD^2*, Chunyan Ji, MD^2*, Chongwu Wang^3*, Yaqiong Ge^3*, Xiaoping Zhou^3*, Julian Gorrochategui^4*, Daniel Primo, PhD^4*, Joan Ballesteros, PhD⁵, Li Li, MD^6* and Joaquin Martinez-López^7*

¹Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou，Zhejiang, China
²Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China
³Hosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China
⁴Vivia Biotech, Tres Cantos, Madrid, Spain
⁵Vivia Biotech, Tres Cantos, MADRID, Spain
⁶Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁷Department of Hematology, Hospital Universitario 12 de Octubre; H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain

Jorge Labrador^1*, Miriam Saiz-Rodríguez^2*, Maria Dunia De Miguel, MD^3*, María Belén Vidriales^4*, Manuel Perez Encinas, MD^5*, Maria Jose Sanchez, MD^6*, Rebeca Cuello, MD^7*, Alicia Roldán Pérez^8*, Susana Vives, MD^9*, Gonzalo Benzo Callejo^10*, Mercedes Colorado Araujo^11*, María García-Fortes^12*, Maria Jose Sayas^13*, Carmen Olivier^14*, Isabel Recio^15*, Diego Conde Royo^16*, Alvaro Bienert Garcia, MD^17*, Maria Vahi^18*, Carmen Muñoz García, PhD^19*, Cristina Seri, MD^20*, Mar Tormo, MD²¹, Ferran Vall-llovera^22*, Maria Angeles Foncillas^23*, David Martínez-Cuadron, MD^24*, Miguel A. Sanz, MD^25,26,27 and Pau Montesinos, MD, PhD^28,29,30*

¹Hematology Department, Research Unit, Hospital Universitario de Burgos, Burgos, Spain
²Research Unit, FBIS-Hospital Universitario de Burgos, Burgos, Spain
³Hematology department, Hospital Universitario de Guadalajara, Guadalajara, Spain
⁴Hematology Service. University Hospital of Salamanca and IBSAL, Salamanca, Spain
⁵Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
⁶Hematology Department, Hospital Universitario Lucus Augusti, Lugo, Spain
⁷Hematology and hemotherapy department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
⁸Hematology and hemotherapy department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain
⁹Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰Hematology Deparment, Hospital Universitario La Princesa, Madrid, Spain
¹¹Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain
¹²Hospital Universitario Virgen De La Victoria, MáLaga, ESP
¹³Hospital Universitario Doctor Peset, Valencia, Spain
¹⁴Hospital General de Segovia, Segovia, Spain
¹⁵Hematology Deparment, Complejo Asistencial de Ávila, Avila, Spain
¹⁶Hematology Deparment, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain
¹⁷Hematology Deparment, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
¹⁸Hospital Universitario Virgen De Valme, Sevilla, ESP
¹⁹Hematology Deparment, Hospital Universitario Virgen Macarena, Sevilla, Spain
²⁰Hematology and hemotherapy department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain
²¹Hospital Clínico Universitario de Valencia, Valencia, Spain
²²Hematology Deparment, Hospital Universitari Mutua Terrasa, Barcelona, Spain
²³Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
²⁴Hospital Universitari i Politècnic La Fe, Valencia, Spain
²⁵Hospital Universitario la Fe, Hematology Department, Department of Medicine, University of Valencia, Valencia, Spain
²⁶Hematology and hemotherapy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
²⁷Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Carlos III, Madrid, Spain
²⁸CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
²⁹Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain
³⁰Programa Español de Tratamientos en Hematologia, PETHEMA, Valencia, Spain

Mecneide Mendes Lins, MD, MMSc^1*, Juliana Teixeira Costa, MD^2*, Alayde Vieira Wanderley, MD^3*, Adriana Seber, MD, MS⁴, Cinthya Rocha, MD^5*, Luciana Nunes Silva, MD^2*, Laudreisa da Costa Pantoja, MD^3*, Gustavo Zamperlini, MD^6*, Valentino Conter, MD^7* and Raul Ribeiro, MD⁸

¹Pediatric Oncology Unit, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, BRA
²Hospital Martagão Gesteira, Salvador, Brazil
³Universidade Federal do Pará, Belem, Brazil
⁴Hospital Samaritano, Sao Paulo, SP, Brazil
⁵Pediatric Oncology Unit, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil
⁶Hospital Samaritano, Sao Paulo, Brazil
⁷Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy
⁸Department of Oncology and Global Medicine, International Outreach Program, St. Jude Children's Research Hospital, Memphis, TN

Ellen Madarang, PharmD^*, Jillian Lykon, PharmD^*, Nina Nguyen, MD^*, Justin M. Watts, MD, Terrence J Bradley, MD and Namrata S Chandhok, MD

University of Miami Sylvester Comprehensive Cancer Center, Miami, FL

Aryeh Pelcovits, MD¹, Brianna Bakow, MD^2*, Jozal Waroich^3*, Pamela C Egan, MD^4,5, Rabin Niroula, MBBS⁶, Adam J Olszewski, MD^5,7 and John L Reagan, MD⁸

¹Warren Alpert Medical School of Brown University, Providence, RI
²Division of Hematology and Oncology, The Warren Alpert Medical School of Brown University, Providence, RI
³Division of Hematology/Oncology, University of Rochester, Rochester, NY
⁴Alpert Medical School of Brown University, Providence, RI
⁵Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI
⁶Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Providence, RI
⁷Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
⁸Division of Hematology/Oncology, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI